Azo dyes on textiles vs German ban - An objective assessment - Part III Another Study

被引：0
|
作者：
机构：
来源：
Colourage | / 8卷 / 41期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Polarographic study of some mono azo dyes in aqueous solutions using direct current and differential pulse polarography. Part (I).
    Mostafa, OI
    Abo-Farha, SA
    El-Fass, MM
    AFINIDAD, 2004, 61 (511) : 232 - 239
  • [22] A mycotoxin-dedicated total diet study in the Netherlands in 2013: Part III - exposure and risk assessment
    Sprong, R. C.
    de Wit-Bos, L.
    te Biesebeek, J. D.
    Alewijn, M.
    Lopez, P.
    Mengelers, M. J. B.
    WORLD MYCOTOXIN JOURNAL, 2016, 9 (01) : 109 - 127
  • [23] Genetic randomization of allogeneic BMT vs drug treatment in chronic myelogenous leukemia:: The German CML study III.
    Hehlmann, R
    Berger, U
    Hochhaus, A
    Reiter, A
    Pfirrmann, M
    Hasford, J
    Heimpel, H
    Hossfeld, DK
    Huber, C
    Kolb, HJ
    Löffler, H
    Pralle, H
    Queisser, W
    Gratwohl, A
    Tobler, A
    BLOOD, 2000, 96 (11) : 141A - 141A
  • [24] NMR vs. molecular modelling Part III - A DFT-GIAO study of a series of 2-X-fluorobenzenes
    Smith, WB
    MAGNETIC RESONANCE IN CHEMISTRY, 1999, 37 (02) : 107 - 109
  • [25] Guidelines for the Sociomedical Assessment of Performance in Patients Suffering from Chronic Non-Malignant Diseases of the Liver and the Bile Ducts (Part III) - for the Medical Assessment Services of the German Pension Fund
    Horn, S.
    Irle, H.
    Knorr, I.
    Pottins, I.
    Rohwetter, M.
    Schuhknecht, P.
    Timner, K.
    Becker, E.
    GESUNDHEITSWESEN, 2009, 71 (8-9) : 489 - 504
  • [26] Objective risk assessment vs standard care for acute coronary syndromes—The Australian GRACE Risk tool Implementation Study (AGRIS): a process evaluation
    Janice Gullick
    John Wu
    Derek Chew
    Chris Gale
    Andrew T. Yan
    Shaun G. Goodman
    Donna Waters
    Karice Hyun
    David Brieger
    BMC Health Services Research, 22
  • [27] Objective risk assessment vs standard care for acute coronary syndromes-The Australian GRACE Risk tool Implementation Study (AGRIS): a process evaluation
    Gullick, Janice
    Wu, John
    Chew, Derek
    Gale, Chris
    Yan, Andrew T.
    Goodman, Shaun G.
    Waters, Donna
    Hyun, Karice
    Brieger, David
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [28] Three-dimensional assessment of facial asymmetry in Class III subjects. Part 1: a retrospective study evaluating postsurgical outcomes
    Deepal Haresh Ajmera
    Richard Tai-Chiu Hsung
    Pradeep Singh
    Natalie Sui Miu Wong
    Andy Wai Kan Yeung
    Walter Yu Hang Lam
    Balvinder S. Khambay
    Yiu Yan Leung
    Min Gu
    Clinical Oral Investigations, 2022, 26 : 4947 - 4966
  • [29] Three-dimensional assessment of facial asymmetry in Class III subjects. Part 1: a retrospective study evaluating postsurgical outcomes
    Ajmera, Deepal Haresh
    Hsung, Richard Tai-Chiu
    Singh, Pradeep
    Wong, Natalie Sui Miu
    Yeung, Andy Wai Kan
    Lam, Walter Yu Hang
    Khambay, Balvinder S.
    Leung, Yiu Yan
    Gu, Min
    CLINICAL ORAL INVESTIGATIONS, 2022, 26 (07) : 4947 - 4966
  • [30] Geographical assessment of efficacy and safety of relugolix: A subgroup analysis from the randomized, phase III HERO study vs leuprolide (LEU) in men with advanced prostate cancer (APC)
    Bossi, A.
    Shore, N. D.
    Tutrone, R.
    Cookson, M. S.
    George, D. J.
    Saltzstein, D. R.
    Akaza, H.
    Brown, B.
    Selby, B.
    Lu, S.
    Walling, J.
    Tombal, B.
    Saad, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S660 - S660
12345